Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2008
10/14/2008US7435745 Methods and compositions for inhibition of angiogenesis
10/14/2008US7435724 Degradation-resistant mononucleoside phosphate compounds
10/14/2008US7435595 Using prokaryotic histone protein as tool in transfer of heterologus nucleotide sequences into cells; improving exogenous gene expression
10/14/2008CA2330359C Reduction of postoperative complications of cardiopulmonary bypass (cpb) surgery
10/14/2008CA2266608C Combination composition in the form of nutritional supplement or pharmaceutical composition for the prevention and therapeutical treatment of degenerative or inflammatory articular disorders
10/09/2008WO2008120801A1 Method of producing antithrombin composition
10/09/2008WO2008120778A1 Composition for promoting ketone compound formation
10/09/2008WO2008119203A1 A purified recombinant batroxobin with high specific activity
10/09/2008WO2008089008A3 Tetrahydrobiopterin prodrugs
10/09/2008WO2008050301A3 2- phenyl- 6-aminocarbonyl- pyrimidine derivatives and their use as p2y12 receptor antagonists
10/09/2008WO2008030836A3 Bcl inhibitors treating platelet excess
10/09/2008US20080249298 use of heparinoid derivatives for the treatment and diagnosis of disorders which can be treated with heparinoids
10/09/2008US20080249147 Emulsion-Stabilized Preparation
10/09/2008US20080249098 peripheral benzodiazepine receptors; 7-fluoro-N,N,5-trimethyl-4-oxo-3-(pyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-carboxamide; for the treatment of various types of peripheral neuropathies, amyotrophic lateral sclerosis
10/09/2008US20080249006 Pharmaceutical Preparation for the Treatment of Shock
10/09/2008US20080248553 Recombinant food-grade microorganism for use as bioreactor in production of monoglutamyl folate
10/09/2008US20080248101 Pharmaceutical composition containing fenofibrate and method for the preparation thereof
10/09/2008US20080248012 Modulator of adenosine triphosphate release from red blood cells; treating and preventing ischemic reperfusion injuries, cardiovascular and vasodilatory diseases
10/09/2008US20080247994 DNA vaccine
10/09/2008US20080247943 Emulsion containing high boiling fluorocarbon; particles coated with lipid, surfactant
10/09/2008DE102007016283A1 Deoxy-D-glucose for producing drug for therapy of arteriosclerosis and arteriothrombosis, particularly for plaque structure in vessel, for preventing or treating restenosis, and for use with compound for continuous release
10/08/2008EP1978362A2 Cross beta structure comprising amyloid binding proteins and methods for detection of the cross beta structure, for modulating cross beta structures fibril formation and for modulating cross beta structure-mediated toxicity
10/08/2008EP1977773A1 Ameliorating agent for aluminum storage disease
10/08/2008EP1977766A1 Drug delivery material
10/08/2008EP1646390B1 A1 adenosine receptor antagonists
10/08/2008EP1379246B1 Nociceptin analogs
10/08/2008EP1141334B1 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof
10/08/2008EP1064298B1 Inhibitors of caspases
10/08/2008EP1032667B1 Platelet specific antigens and their pharmacological uses
10/08/2008EP0752005B1 Compacted nucleic acids and their delivery to cells
10/08/2008CN101283025A Biodegradable particle and method for producing the same
10/08/2008CN101282974A Benzimidazole derivatives as SIRTUIN modulators
10/08/2008CN101282968A Novel polymorphous form and the amorphous form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
10/08/2008CN101282926A S1p3 receptor antagonist
10/08/2008CN101282761A Benzimidazole derivatives as SIRTUIN modulators
10/08/2008CN101280296A Trimeresurus albolabris defibrase, preparation thereof and application thereof to pharmacy
10/08/2008CN101280001A Preparation of human SDF-1 alpha, human SDF-1 alpha obtained therefrom and use thereof
10/08/2008CN101279089A Donkey-hide gelatin calcium composition and preparing process thereof
10/08/2008CN101279068A Chinese medicinal composition for treating leukemia and preparation method thereof
10/08/2008CN101279052A Haemostatic and uses thereof and preparation
10/08/2008CN101279044A Chinese medicinal composition for curing aplastic anemia and preparation method thereof
10/08/2008CN101279017A Yunnan hongyao extract and extracting method thereof and application
10/08/2008CN101279016A Oral medicament for curing craniocerebral injury associated with hydrocephalus
10/08/2008CN101279013A Chinese medicine compound for curing chronic type aplastic anemia
10/08/2008CN101278995A Medicament for curing rhinorrhagia, gastrorrhagia and menoxenia
10/08/2008CN101278987A Chinese medicine compound for nourishing yin and tonifying kidney, benefiting-qi and promoting blood circulation, enriching blood and benefiting semen
10/08/2008CN101278971A Chinese medicinal composition for curing puffiness and edema
10/08/2008CN101278970A Method for preparing Elsholtzia bodinieri flavonoid and applications
10/08/2008CN101278966A Quality control method of phyllanthus urinaria oral preparation
10/08/2008CN101278965A Soft capsule of humifuse spurge and preparing method thereof
10/08/2008CN101278926A Applications of iron chelator in preparation of medicament for preventing or curing hemorrhagic cerebrovascular disease and chronic hydrocephalus after craniocerebral injury
10/08/2008CN101278922A Medicament composition capsule and method of preparing the same
10/08/2008CN101278742A Sweet goods of ass jelly series
10/08/2008CN101278731A Donkey-hide gelatin maltose food, drink and preparation method
10/08/2008CN100424182C Methods for detecting and treating the early onset of aging-related conditions
10/08/2008CN100424172C Oriented mutant gene engineering barr kinase and its use
10/08/2008CN100424171C High purity venom fibrinolysin prepartion method and its pharmaceutical formulation
10/08/2008CN100424079C Bis-sulfonamides
10/08/2008CN100423777C Glycoprotein compositions
10/08/2008CN100423773C Application of edestin in preparation of medicament
10/08/2008CN100423730C Medium and method for preserving platelets, red blood cells, and other non-nucleus cells and platelets-containing composition
10/08/2008CN100423721C Thrombopoietin mimetics
10/07/2008US7432389 Inhibiting beta-secretase enzyme activity and A beta peptide production, to reduce amyloid beta deposits or plaques
10/07/2008US7432360 Containing 0.001 to 0.01% w/v benzethonium chloride and 0.01 to 0.5% w/v phenoxyethanol or 0.01 to 0.5% w/v phenylethyl alcohol as preservatives; vials for parenteral administration
10/07/2008US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
10/07/2008US7432286 Pharmaceutically active sulfonyl hydrazide derivatives
10/07/2008US7432285 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/07/2008US7432243 A nucleic acid molecule that encodes at least one polypeptide useful as antiangiogenic, tumor suppressive and antimigratory agent
10/07/2008US7431925 Internal image antibodies for optical imaging and therapy
10/07/2008CA2444071C Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
10/07/2008CA2427573C Indole derivatives as pde5-inhibitors
10/07/2008CA2411544C N-alkyl-adamantyl triazinyl benzamide derivatives
10/07/2008CA2305926C Stable crystalline salts of 5-methyltetrahydrofolic acid
10/07/2008CA2223449C Peptides and compounds that bind to the thrombopoietin receptor
10/02/2008WO2008118790A1 Dihydroindazole compounds useful in treating iron disorders
10/02/2008WO2008118164A1 Compounds to promote regeneration of bone marrow
10/02/2008WO2008117862A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure
10/02/2008WO2008117814A1 Oral pharmaceutical preparation for colon-specific delivery
10/02/2008WO2008117735A1 Method for producing soluble thrombomodulin of high purity
10/02/2008WO2008116887A2 The use of peritoneal mast cells as a heparin source
10/02/2008WO2008116881A1 Substituted pyrrolidine amides, the production thereof, and the use thereof as medications
10/02/2008WO2008067126A3 Methods for using aldhbr cells to supplement stem cell transplantation
10/02/2008US20080242644 Therapy, prevention of thromboembolic disease, cancer and rheumatic diseases
10/02/2008US20080241961 Drosophila g protein coupled receptors, nucleic acids, and mehtods related to the same
10/02/2008US20080241960 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders
10/02/2008US20080241218 Intravascular stent having an iridium oxide, gold, platinum, titanium or inert carbon coating, and a number or reservoirs with an antibiotic, anticoagulant, antiproliferative, bactericide, angiogenesis inhibitor, growth factor, or radionuclide; greater control of drug placement and coating durability
10/02/2008US20080241165 Controlling extracellular protein degradation and/or clearance via modulation of tissue plasminogen activator activity; treating diabetic, autoimmune, cardiovascular, blood and nervous system disorders
10/02/2008US20080241158 G-protein coupled receptors for use in identifying modulators for treatment and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, metabolic and viral disorders
10/02/2008US20080241143 Using selectin therapeutic in treatment of inflammatory bowel and joint disorders
10/02/2008US20080241134 Uses of human monoclonal antibodies against oxidized ldl receptor
10/02/2008US20080241099 Inhibitors of MBP 85-99 or proteolipid protein (PLP) 40-60-specific HLA-DR-2-restricted T cell clones; multiple sclerosis; rheumatoid arthritis; solid phase synthesis; kits
10/02/2008DE102007015034A1 Lactam-substituierte Dicarbonsäuren und ihre Verwendung Lactam substituted dicarboxylic acids and their use
10/02/2008CA2684655A1 Oral pharmaceutical preparation for colon-specific delivery
10/02/2008CA2682012A1 Substituted pyrrolidinamides, manufacturing and use thereof as medicaments
10/02/2008CA2681294A1 Method for producing high-purity soluble thrombomodulin
10/02/2008CA2680517A1 Novel pyridinecarboxylic acid (2-aminophenyl)amide derivative having urea structure
10/01/2008EP1975165A1 Substituted pyrrolidinamides, their production and utilisation as medicine
10/01/2008EP1975164A2 Octahydrobenzimidazolone compounds as analgetics
10/01/2008EP1974741A1 Dried blood factor composition stabilised by trehalose
10/01/2008EP1973568A1 Cytotoxic antibodies targeting antibodies inhibiting factor viii
1 ... 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 ... 671